Argent Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Argent Financial Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.47M	Buy	+2,353	New	+$2.62M	0.29%	90

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Argent Financial Group's REGN Position: Q3 2024 in Review

Argent Financial Group opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2024: 2,353 shares worth $2.47M. The stake represents 0.29% of the portfolio and ranks #90 among its holdings.

1,388 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

Argent Financial Group held 2,353 shares of Regeneron Pharmaceuticals worth $2.47M as of Q3 2024.
Regeneron Pharmaceuticals was a new Argent Financial Group position in Q3 2024.
Regeneron Pharmaceuticals made up 0.29% of Argent Financial Group's portfolio in Q3 2024, its #90 holding.
1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Argent Financial Group's 13F filing for Q3 2024, filed 13 Nov 2024.